Skip to search formSkip to main contentSkip to account menu

Dipeptidyl-Peptidase IV

Known as: CD26 Antigens, Dipeptidyl Peptidase IV, CD26 
A serine protease that catalyses the release of an N-terminal dipeptide. Several biologically-active peptides have been identified as dipeptidyl… 
National Institutes of Health

Related topics

Related topics

13 relations
Adenosine deaminase binding protein:MCnc:Pt:Urine:QnDPP4 geneIn BloodProcess of secretion

Broader (2)

CD AntigensDPP4 wt Allele

Narrower (2)

DPP4 protein, humanDPP4 protein, rat

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
A Retrospective, Case-Note Survey of Type 2 Diabetes Patients Prescribed Incretin-Based Therapies in Clinical Practice
IntroductionWhile incretin-based therapies have been compared in clinical trials, data comparing their relative efficacy in… 
Highly Cited
2009
Highly Cited
2009
Evaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DPP-4 inhibitor linagliptin and metformin in healthy subjects
ABSTRACT Objective: Linagliptin (BI 1356) is a novel, orally available inhibitor of dipeptidyl peptidase-4 (DPP-4). Linagliptin… 
2005
2005
Removal of poly-histidine fusion tags from recombinant proteins purified by expanded bed adsorption.
Enzymatic methods have been used to cleave the C- or N-terminus polyhistidine tags from histidine tagged proteins following… 
Highly Cited
1996
Highly Cited
1996
Serum high molecular weight dipeptidyl peptidase IV (CD26) is similar to a novel antigen DPPT-L released from activated T cells.
This study demonstrates that the 175-kDa form of dipeptidyl peptidase IV (DPPIV) found in normal human serum is identical with a… 
Highly Cited
1996
Highly Cited
1996
Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis.
OBJECTIVE To investigate the activation of T cells in peripheral blood (PB) and synovial fluid (SF) of patients with rheumatoid… 
1996
1996
Studies of HIV‐1 envelope glycoprotein‐mediated fusion using a simple fluorescence assay
ObjectiveTo study HIV envelope glycoprotein (Env)-mediated entry using a sensitive fusion assay. Design and methodsCD4… 
1995
1995
Unchanged signaling capacity of mutant CD26/dipeptidylpeptidase IV molecules devoid of enzymatic activity.
CD26 is a proteolytic enzyme (dipeptidylpeptidase IV) that defines an alternative activation signal for human T lymphocytes… 
1993
1993
Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells.
CD26 (Tp103) is a proteolytic enzyme (dipeptidyl peptidase IV) expressed on the T cell surface that defines an alternative… 
Highly Cited
1993
Highly Cited
1993
Separation of L-Pro-DL-boroPro into its component diastereomers and kinetic analysis of their inhibition of dipeptidyl peptidase IV. A new method for the analysis of slow, tight-binding inhibition.
The potent dipeptidyl peptidase IV (DP IV) inhibitor [1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinyl]boronic acid (L-Pro-DL-boroPro… 
Highly Cited
1978
Highly Cited
1978
Human adenosine deaminase binding protein. Assay, purification, and properties.
In many human tissues adenosine deaminase exists as a complex composed of two proteins; one protein has adenosine deaminase… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)